Steven McAuley, Empower Clinics CEO, to Speak at Peak Asset Management’s Psychedelic Investment Webinar and Provides Corporate Update

Empower CEO, Steven McAuley, will speak at the Peak Asset Management’s Webinar on Thursday June 18th at 7:30PST and announces Management Cease Trade Order has been approved by BC Securities Commission effective June 16, 2020

VANCOUVER BC / ACCESSWIRE / June 16, 2020 / EMPOWER CLINICS INC. (CSE:CBDT)(OTCQB:EPWCF)(Frankfurt:8EC) (“Empower” or the “Company“), a vertically integrated life sciences company, is pleased to announce that Empower CEO Steven McAuley will be speaking at the Peak Asset Management’s Psychedelic Investment Webinar this Thursday, June 18th at 7:30PST. The Webinar is titled: “Psychedelic Stocks On The Charge in North America Creates Opportunities for Global Investors” and is being hosted by Peter Hunt, Co-founder and Chair of Mind Medicine Australia.

The Webinar will include talks and Q&A from the following Companies:

  • Mind Medicine Australia – working with the Therapeutic Goods Administration to bring these medicines to everyday Australians
  • Eleusian Biosciences Corp – leveraging Psilocybin to treat depression & concussion
  • Empower Clinics – operates six health & wellness clinics in the USA treating patients in real-time ,in person and through tele-medicine

More information and registration for the webinar can be found at: Psychedelic Stocks on the Charge (CTR Click)

“Having the opportunity to participate in the Peak Asset Management’s Psychedelics Webinar in front of a diverse international audience, allows me to advocate for the impact psychedelic treatments may have for global mental health issues.” said Steven McAuley, Chairman & CEO of Empower. “Being part of the conversation on behalf of our new psychedelics division Dosed Wellness, brings important exposure to the overall narrative.”

The Company has amended the application for a management cease trade order (“MCTO“) from filing with the Ontario Securities Commission to an updated filing with the British Columbia Securities Commission, which would restrict all trading in securities of the Company, whether direct or indirect, by the Chief Executive Officer and Chief Financial Officer of the Company. The issuance of an MCTO does not generally affect the ability of persons who are not directors, officers or other insiders of the Company to trade in securities of the Company.

The Company confirms that the BC Securities Commission has approved the application for MCTO effective June 16, 2020

As required under section 9 b) of the National Policy 12-203 – Cease Trade Orders the Company indicates it is unable to meet the prescribed filing deadline due to additional audit requirements by its auditor MNP, LLP and due to increased operational limitations related to the coronavirus pandemic.

The Company intends to comply with the provisions of the alternative information guidelines as set out in the National Policy 12-203 – Cease Trade Orders for Continuous Disclosure Defaults for as long as it remains in default, including the issuance of bi-weekly default status reports, each of which will be issued in the form of a news release.


Empower is a vertically integrated health & wellness company with a network of corporate and franchised health & wellness clinics in the U.S. The Company is focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The Company has launched Dosed Wellness Ltd. to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies, psilocybin and other psychedelic plant-based treatment options.


Steven McAuley
Chief Executive Officer


Investors: Steven McAuley
Chairman & CEO

Investors: Dustin Klein
SVP, Business Development


For French inquiries:

Remy Scalabrini, Maricom Inc.,
T: (888) 585-MARI


This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release.Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding: the Company’s expected timing of filing of its Annual Filings, the Company’s intention to create psilocybin and psychedelics divisions, that market research on advancements in psilocybin and psychedelics in North America and globally will create greater shareholder value, the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empowers patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond; the ability of the Company to complete or execute phases One, Two, Three or Four of COVID-19 test programs, and Psychedelic substances remain illegal in most countries, so please reference your local laws in relation to medical or recreational use. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

SOURCE: Empower Clinics Inc.

View source version on

error: Content is protected !!